Vaccines, blood, antisera, toxins and cultures in   United Kingdom

Overview In June 2024 United Kingdom's Vaccines, blood, antisera, toxins and cultures exports accounted up to £406M and imports accounted up to £641M, resulting in a negative trade balance of £235M. Between June 2023 and June 2024 the exports of United Kingdom's   Vaccines, blood, antisera, toxins and cultures have decreased by £-45.8M (-10.1%) from £452M to £406M, while imports increased by £59.1M (10.2%) from £582M to £641M.

Destinations In June 2024, Vaccines, blood, antisera, toxins and cultures were exported mostly to United States (£159M), France (£61M), Germany (£19.9M), Switzerland (£16M), and Saudi Arabia (£15.9M), and were imported mostly from Belgium (£175M), Netherlands (£102M), United States (£89M), Switzerland (£68.2M), and Germany (£64.2M).

Growth In June 2024, the decrease in Vaccines, blood, antisera, toxins and cultures's year-by-year exports was explained primarily by a decrease in exports to Russia (£-4.24M or -88.4%), Mexico (£-3.22M or -74.5%), and Sweden (£-2.1M or -53.4%). In June 2024, the increase in Vaccines, blood, antisera, toxins and cultures's year-by-year imports was explained primarily by an increase in imports from Belgium (£82.8M or 182%), Germany (£60.5M or 89.5%), and Netherlands (£33.2M or 57.2%).